Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target

被引:33
作者
Miller, Laurence J. [1 ]
Desai, Aditya J. [1 ]
机构
[1] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA
关键词
VAGAL AFFERENT NEURONS; HUMAN CCK1 RECEPTOR; INTERMEAL INTERVAL; FOOD-INTAKE; MOLECULAR-BASIS; BINDING-SITE; MEAL SIZE; ENDOGENOUS CHOLECYSTOKININ; PANCREATIC-POLYPEPTIDE; GASTROINTESTINAL SITES;
D O I
10.1016/j.tem.2016.04.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cholecystokinin (CCK) regulates appetite and reduces food intake by activating the type 1 CCK receptor (CCK1R). Attempts to develop CCK1R agonists for obesity have yielded active agents that have not reached clinical practice. Here we discuss why, along with new strategies to target CCK1R more effectively. We examine signaling events and the possibility of developing agents that exhibit ligand-directed bias, to dissociate satiety activity from undesirable side effects. Potential allosteric sites of modulation are also discussed, along with desired properties of a positive allosteric modulator (PAM) without intrinsic agonist action as another strategy to treat obesity. These new types of CCK1R-active drugs could be useful as standalone agents or as part of a rational drug combination for management of obesity.
引用
收藏
页码:609 / 619
页数:11
相关论文
共 83 条
[1]   Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity .1. Optimization of the agonist ''Trigger'' [J].
Aquino, CJ ;
Armour, DR ;
Berman, JM ;
Birkemo, LS ;
Carr, RAE ;
Croom, DK ;
Dezube, M ;
Dougherty, RW ;
Ervin, GN ;
Grizzle, MK ;
Head, JE ;
Hirst, GC ;
James, MK ;
Johnson, MF ;
Miller, LJ ;
Queen, KL ;
Rimele, TJ ;
Smith, DN ;
Sugg, EE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :562-569
[2]   The stomach is a source of leptin [J].
Bado, A ;
Levasseur, S ;
Attoub, S ;
Kermorgant, S ;
Laigneau, JP ;
Bortoluzzi, MN ;
Moizo, L ;
Lehy, T ;
Guerre-Millo, M ;
Le Marchand-Brustel, Y ;
Lewin, MJM .
NATURE, 1998, 394 (6695) :790-793
[3]   G protein-coupled receptor desensitization as a measure of signaling: Modeling of arrestin recruitment to activated CCK-B receptors [J].
Barak, LS ;
Oakley, RH ;
Shetzlinef, MA .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (03) :409-424
[4]   Synergy between amylin and cholecystokinin for inhibition of food intake in mice [J].
Bhavsar, S ;
Watkins, J ;
Young, A .
PHYSIOLOGY & BEHAVIOR, 1998, 64 (04) :557-561
[5]   Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin [J].
Burdyga, G ;
Lal, S ;
Varro, A ;
Dimaline, R ;
Thompson, DG ;
Dockray, GJ .
JOURNAL OF NEUROSCIENCE, 2004, 24 (11) :2708-2715
[6]   Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans [J].
Burdyga, G ;
Lal, S ;
Spiller, D ;
Jiang, W ;
Thompson, D ;
Attwodd, S ;
Saeed, S ;
Grundy, D ;
Varro, A ;
Dimaline, R ;
Dockray, GJ .
GASTROENTEROLOGY, 2003, 124 (01) :129-139
[7]   Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor [J].
Cawston, Erin E. ;
Lam, Polo C. H. ;
Harikumar, Kaleeckal G. ;
Dong, Maoqing ;
Ball, Alicja M. ;
Augustine, Mary Lou ;
Akguen, Eyup ;
Portoghese, Philip S. ;
Orry, Andrew ;
Abagyan, Ruben ;
Sexton, Patrick M. ;
Miller, Laurence J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (22) :18618-18635
[8]   Advances in G Protein-Coupled Receptor Allostery: From Function to Structure [J].
Christopoulos, Arthur .
MOLECULAR PHARMACOLOGY, 2014, 86 (05) :463-478
[9]   Association of plasma markers of cholesterol homeostasis with metabolic syndrome components. A cross-sectional study [J].
Cofan, M. ;
Escurriol, V. ;
Garcia-Otin, A. L. ;
Moreno-Iribas, C. ;
Larranaga, N. ;
Sanchez, M. J. ;
Tormo, M. J. ;
Redondo, M. L. ;
Gonzalez, C. A. ;
Corella, D. ;
Pocovi, M. ;
Civeira, F. ;
Ros, E. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (09) :651-657
[10]   Peripheral interaction of ghrelin with cholecystokinin on feeding regulation [J].
Date, Y ;
Toshinai, K ;
Koda, S ;
Miyazato, M ;
Shimbara, T ;
Tsuruta, T ;
Niijima, A ;
Kangawa, K ;
Nakazato, M .
ENDOCRINOLOGY, 2005, 146 (08) :3518-3525